FDA Inspection 1254769 — Finecure Pharmaceuticals Limited

Finecure Pharmaceuticals Limited — FEI 3020233232

The FDA completed an inspection of Finecure Pharmaceuticals Limited on November 22, 2024 in Ahmedabad. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 22, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ahmedabad (India)

Citations

IDCFRDescription
192021 CFR 211.166(a)(3)Valid stability test methods